Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (2)
Azerbaijan (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Kazakhstan (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Russia (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
Thailand (1)
The Phillippines (1)
United Arab Emirates (1)
United Kingdom (3)
Uzbekistan (1)
Explore our news
Norbitec biotech facility in Uetersen, Germany, a company controlled by STADA, passes inspection by the US FDA
Ranibizumab biosimilar is being launched in major European markets
Full year 2022 results
STADA Health Report 2022
Europe, early summer 2021: Covid vaccination programmes across Europe were in full flow, bringing the prospect of returning to life more like we knew it before the pandemic. But had the virus changed the way we lived irreversibly? By asking detailed questions of 30,000 people across 15 countries, the STADA Health Report 2021 brought to light the immediate short-term effects of the pandemic on the lives of Europeans.
One year later, STADA checked in with Europeans to learn what longer-term effects the pandemic has left on Europe’s health landscape: How is their mental health holding up? What is worrying them? All the answers can be found in the STADA Health Report 2022
STADA on Social Media
Get in touch
For Journalists
STADA Arzrneimittel AG
Media Relations
61118 Bad Vilbel
For Customers, Business Partners & general inquiries
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel